NovoCare

Deep dive

NovoCare: complete reference

NovoCare is Novo Nordisk's patient support and savings program covering all Novo GLP-1 medications: Wegovy, Ozempic, Saxenda, Rybelsus, Victoza. The program structure: commercial-insurance savings cards reducing copays to $0-25/month с annual caps (~$3,600), uninsured savings program (Wegovy: up to ~$650/month vs $1,349 retail), and a Patient Assistance Program (PAP) для income-qualified uninsured patients getting medication at no cost. Eligibility exclusions: Medicare, Medicaid, federally-funded plans (TRICARE, VA), per federal anti-kickback rules. Application typically requires prescriber co-signature, insurance documentation, and patient attestation. NovoCare also offers educational materials, injection-training videos, and dose reminder support. Important caveat: savings program eligibility is reviewed annually; patients should re-enroll или re-verify status each year.

In practice

If your commercial insurance covers Wegovy с a $300/month copay, NovoCare savings card brings that to $0-25 (depending on plan), capped at ~$3,600 annual savings.

Clinical context

NovoCare is the standard cost-reduction pathway для Novo Nordisk GLP-1s. Always check eligibility — exclusions are firm.